Molecular Products Group India Private Limited, a active foreign private limited company, was established on 12 January 2016 in Thane, Maharashtra, India. Engaging in consumer professional services within the support service to organizations sector, it holds CIN: U74120MH2016FTC271967. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹3.95 M.
It upholds a compliant status. Its leadership includes Jan Willem Radstaak (Director), Brandon Christopher Smith (Director), Kelly Anne Reinke (Director). Past directors included Jan Willem Radstaak, Joseph Manuel Carloto, John Troy Rhudy. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No - 72,, H T Industrial Complex, Thane (W),, Thane, Maharashtra, 400604.
U74120MH2016FTC271967
271967
12 January 2016
₹4.00 M
₹3.95 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Molecular Products Group India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jan Willem Radstaak | Director | 03 Jun 2021 | Current |
| Brandon Christopher Smith | Director | 26 May 2023 | Current |
| Kelly Anne Reinke | Director | 26 May 2023 | Current |
| Vikrant Bapusaheb Patil | Director | 12 Jan 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 31 Jul 2017 | Past |
| Pramod Abcsdd | Director | 30 Apr 2017 | Past |
| Pramod Abcsdd | Director | 26 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Molecular Products Group India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 43.24% decrease. The company also saw a substantial fall in profitability, with a 113.76% decrease in profit. The company's net worth dipped by a decrease of 4.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Molecular Products Group India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Molecular Products Group India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Molecular Products Group India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecular Products Group India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Molecular Products Group India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Molecular Products Group India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Brandon Christopher Smith was appointed as a Director was appointed as a Director on 26 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
The activity Kelly Anne Reinke was appointed as a Director was appointed as a Director on 26 May 2023 & has been associated with this company since 2 years 7 months . was completed.
Progress on Jan Willem Radstaak was appointed as a Director was appointed as a Director on 03 Jun 2021 & has been associated with this company since 4 years 7 months . was documented.
Progress on Vikrant Bapusaheb Patil was appointed as a Director was appointed as a Director on 12 Jan 2016 & has been associated with this company since 10 years 1 day . was documented.
The CIN of Molecular Products Group India Private Limited is U74120MH2016FTC271967.
Molecular Products Group India Private Limited is headquartered at Plot No - 72,, H T Industrial Complex, Thane (W),, Thane, Maharashtra, 400604.
Molecular Products Group India Private Limited was incorporated on 12 January 2016.
The current directors of Molecular Products Group India Private Limited are
The primary industry of Molecular Products Group India Private Limited is Support Service To Organizations.
Molecular Products Group India Private Limited is unlisted.
The authorized capital of Molecular Products Group India Private Limited is ₹4.00 M, and the paid-up capital is ₹3.95 M.
The compliance status of Molecular Products Group India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX